Past, Current and Future Techniques for Monitoring Paralytic Shellfish Toxins in Bivalve Molluscs

Abstract

Paralytic shellfish poisoning is a threat to human health caused by the consumption of shellfish contaminated with toxins of the saxitoxin class. Human health is protected by the setting of regulatory limits and the analysis of shellfish prior to sale. Both robust toxicity data, generated from experiments fitting into the ethical 3R framework, and appropriate analysis methods are required to ensure the success of this approach. A literature review of in vivo animal bioassays and in vitro and analytical methods showed that in vitro methods are the best option to screen shellfish for non-regulatory purposes. However, since neither the receptor nor antibody binding of paralytic shellfish toxin analogues correlate with toxicity, these assays cannot accurately quantify toxicity in shellfish nor be used to calculate toxicity equivalence factors. Fully replacing animals in testing is rightfully the ultimate goal, but this cannot be at a cost to human health. More modern technology, such as organ-on-a-chip, represent an exciting development, but animal bioassays cannot currently be replaced in the determination of toxicity. Analytical methods that employ toxicity equivalence factors calculated using oral animal toxicity data result in an accurate assessment of the food safety risk posed by paralytic shellfish toxin contamination in bivalve molluscs.